Vanguard Personalized Indexing Management
NMRA icon

Vanguard Personalized Indexing Management’s Neumora Therapeutics NMRA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97K Sell
57,040
-4,992
-8% -$9.5K ﹤0.01% 2059
2026
Q1 		$121K Sell
62,032
-2,871
-4% -$7.44K ﹤0.01% 1926
2025
Q4 		$116K Buy
64,903
+474
+0.7% +$1.04K ﹤0.01% 1792
2025
Q3 		$117K Buy
64,429
+6,233
+11% +$10.1K ﹤0.01% 1793
2025
Q2 		$42.7K Buy
58,196
+32,922
+130% +$24.9K ﹤0.01% 1849
2025
Q1 		$25.3K Buy
+25,274
New +$43.3K ﹤0.01% 1748

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Personalized Indexing Management's NMRA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Neumora Therapeutics (NMRA) stake by 8% in Q2 2026, selling an estimated $9.5K and leaving 57,040 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Vanguard Personalized Indexing Management first reported a position in NMRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $121K in Q1 2026. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 57,040 shares of Neumora Therapeutics worth $97K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 4,992 Neumora Therapeutics shares in Q2 2026, an estimated $9.5K.
  • Neumora Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2059 holding.
  • Vanguard Personalized Indexing Management first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Vanguard Personalized Indexing Management's Neumora Therapeutics position peaked at $121K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.